Current Clinical Guidance

Filter Standards and Guidance documents

CEU Statement Quick Starting After UPA - Sept 2015

Faculty of Sexual and Reproductive Healthcare (FSRH) response to new data on quickstarting hormonal contraception after use of ulipristal acetate 30mg (ellaOne®) for emergency contraception Sept 2015.

This document is up-to-date

FSRH Clinical Guidance: Problematic Bleeding with Hormonal Contraception (July 2015)

This guidance provides evidence-based recommendations and good practice points for health professionals on the management of problematic bleeding in women using hormonal contraception currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK.

This document is up-to-date

FSRH Clinical Guidance: Fertility Awareness Methods (June 2015)

This is a new guidance document that provides evidence-based recommendations and good practice points on the use of fertility awareness methods (FAM) for the purpose of preventing and/or spacing pregnancies. It is intended for any health care professional or health service providing contraception or conception advice in the UK.

This document is up-to-date

CEU Guidance: Intrauterine Contraception (April 2015)

This guidance provides evidence-based recommendations and good practice points for health professionals on the use of intrauterine contraception (IUC) currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK.

This document is up-to-date

FSRH Clinical Guidance: Progestogen-only Pills (March 2015)

This guidance provides evidence-based recommendations and good practice points on use of the progestogen-only pill (POP). It is intended for any health professional or service providing contraception or contraceptive advice in the UK.

This document is up-to-date

FSRH Clinical Guidance: Progestogen-only Injectable contraception (December 2014)

This guidance provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only injectables currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK. This guidance is not up-to-date. Please refer to CEU statements published on the topic for update to this guidance.

This document is not current and may have been updated

CEU Statement Venous Thromboembolism

The BMJ today publishes the findings of a large UK observational study by Vinogradova et al looking at the association between combined oral contraception (COC) and risk of venous thromboembolism (VTE) May 2015.

This document is up-to-date

FSRH Clinical Guidance: Male and Female Sterilisation (September 2014)

This guidance provides evidence-based recommendations and good practice points for health professionals on elective male sterilisation (vasectomy) and female sterilisation (tubal occlusion) in the UK. It is intended for any health care professional or service that undertakes or refers individuals for either procedure. This guidance has been jointly developed with the Royal College of Obstetricians and Gynaecologists (RCOG).

This document is up-to-date

FSRH Clinical Guidance: Progestogen-only Implants (February 2014)

This guidance provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only implants currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK. This guidance is not up-to-date. Please refer to CEU statements published on the topic for update to this guidance.

This document is not current and may have been updated

Faculty Statement Combined Pill

The FSRH statement in response to the Combined Pill Communication from the Medicines and Healthcare products Regulatory Agency (MHRA) February 2014.

This document is up-to-date